FDA Inspection 1221034 — MediBeacon, Inc
The FDA completed an inspection of MediBeacon, Inc on Oct 13, 2023 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 13, 2023
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Saint Louis, MO (United States)
Additional Details
Sponsor, Contract Research Organization